GW117: A novel serotonin (5-HT2C) receptor antagonist and melatonin (MT1/MT2) receptor agonist with potential antidepressant-like activity in rodents

被引：10

作者：

Gao, Nana ^{[1
]}

Zheng, Wei ^{[2
]}

Murezati, Tiliwaerde ^{[2
]}

Gu, Wei ^{[3
]}

Li, Xiaorong ^{[2
]}

Jin, Zengliang ^{[2
]}

机构：

[1] Captial Med Univ, Beijing Shijitan Hosp, Dept Gastrointestinal Surg & Clin Nutr, Beijing, Peoples R China

[2] Capital Med Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing 100069, Peoples R China

[3] Beijing Guangwei Pharmaceut Technol Co Ltd, Beijing, Peoples R China

来源：

CNS NEUROSCIENCE & THERAPEUTICS | 2021年 / 27卷 / 06期

基金：

中国国家自然科学基金;

关键词：

5‐ HT2C receptor; antidepressant; GW117; melatonin receptor; REUPTAKE INHIBITORS; AGOMELATINE; NOREPINEPHRINE; DRUGS; MODEL; DEPRESSION; STRESS; RATS;

D O I：

10.1111/cns.13630

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Aims To evaluate the antidepressant-like effect of compound GW117 in rodents using in vitro binding and uptake assays as well in vivo behavioral tests. Methods We investigated the target profile of GW117 using [S-35]-GTP gamma S and [H-3]PIP binding. Using the forced swimming test and chronic unpredictable stress in rats, tail suspension test in mice and rats, and learned helplessness model in mice, we further revealed the antidepressant-like and anxiolytic-like effects of GW117. Results The current study suggests that GW117 displays serotonin 2C (5-HT2C) receptor antagonist and melatonin type 1 and 2 (MT1/MT2) receptor agonist properties, as well as evident antidepressant and anxiolytic effects. Conclusion These data suggest that GW117 is probably a potent antidepressant.

引用

页码：702 / 713

页数：12

共 50 条

[21] A Case of Unilateral Hypnic Headache: Rapid Response to Ramelteon, a Selective Melatonin MT1/MT2 Receptor Agonist
Arai, Motomi
HEADACHE, 2015, 55 (07): : 1010 - 1011
[22] MT1 and MT2 melatonin receptor expression in mammalian vasculature and superior cervical ganglion
Masana, MI
Al-Ghoul, W
Dubocovich, ML
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R72 - R72
[23] Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers
Ayoub, MA
Levoye, A
Delagrange, P
Jockers, R
MOLECULAR PHARMACOLOGY, 2004, 66 (02) : 312 - 321
[24] Novel selective melatonin MT2 receptor agonist in the treatment of insomnia
Gobbi, G.
Comai, S.
Ochoa-Sanchez, R.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S144 - S144
[25] QSAR study and design of melatonin receptor ligands for mt1 and MT2 receptors.
Esposito, EX
Madura, JD
Li, PK
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U291 - U291
[26] Human amniotic epithelial cells express melatonin receptor MT1, but not melatonin receptor MT2: a new perspective to neuroprotection
Kaneko, Yuji
Hayashi, Takuro
Yu, SeongJin
Tajiri, Naoki
Bae, Eunkyung C.
Solomita, Marianna A.
Chheda, Sonia H.
Weinbren, Nathan L.
Parolini, Ornella
Borlongan, Cesar V.
JOURNAL OF PINEAL RESEARCH, 2011, 50 (03) : 272 - 280
[27] Pharmacology of Ramelteon, a Selective MT1/MT2 Receptor Agonist: A Novel Therapeutic Drug for Sleep Disorders
Miyamoto, Masaomi
CNS NEUROSCIENCE & THERAPEUTICS, 2009, 15 (01) : 32 - 51
[28] Insomnia medication and QOL: Research and development of ramelteon, an MT1/MT2 receptor agonist
Miyamoto, Masaomi
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 44P - 44P
[29] Molecular pharmacology of the ovine melatonin receptor:: comparison with recombinant human MT1 and MT2 receptors
Mailliet, F
Audinot, V
Malpaux, B
Bonnaud, A
Delagrange, P
Migaud, M
Barrett, P
Viaud-Massuard, MC
Lesieur, D
Lefoulon, F
Renard, P
Boutin, JA
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (04) : 667 - 677
[30] Comparison of CoMFA and QSAR in the study of melatonin receptor ligands for mt1 and MT2 receptors.
Madura, JD
Esposito, E
Li, PK
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U607 - U607

← 1 2 3 4 5 →